The European Medicines Agency (EMA) approved, this Thursday, in case of emergency, the use in the European Union of Paxlovid, the anti-Covid pill from Pfizer, which has not yet received full authorization of marketing, announced the body in a press release published on its site.

“The drug, which is not yet authorized in the EU, can be used to treat adults with Covid-19 who do not need supplemental oxygen and who are at increased risk of developing a severe form of disease, ”the EMA said in a statement.

On Tuesday, the American firm had confirmed the very positive results of its anti-Covid-19 pill.

Almost 90% hospitalizations related to Covid-19 and deaths reduced in people at risk when taken in the first days after the onset of symptoms.

No deaths were recorded among the more than 2,200 study participants who received the treatment.

Participants were unvaccinated and at high risk of developing a severe case of Covid-19.

World

Coronavirus: United States orders ten million Pfizer anti-Covid pill

Society

Coronavirus in the European Union: Has Brussels planned seven doses per person?

Caution…

  • Covid 19

  • EU

  • Video

  • Pfizer-BioNTech

  • Medication

  • World

  • Coronavirus

  • 0 comment

  • 0 share

    • Share on Messenger

    • Share on Facebook

    • Share on twitter

    • Share on Flipboard

    • Share on Pinterest

    • Share on Linkedin

    • Send by Mail

  • To safeguard

  • A fault ?

  • To print